Cullinan Oncology Inc. (CGEM)
NASDAQ: CGEM
· Real-Time Price · USD
7.50
0.26 (3.59%)
At close: May 16, 2025, 3:59 PM
7.50
0.00%
After-hours: May 16, 2025, 04:20 PM EDT
3.59% (1D)
| Bid | 5.88 |
| Market Cap | 442.61M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -178.74M |
| EPS (ttm) | -2.77 |
| PE Ratio (ttm) | -2.71 |
| Forward PE | -2.32 |
| Analyst | Buy |
| Ask | 8 |
| Volume | 329,594 |
| Avg. Volume (20D) | 473,953 |
| Open | 7.23 |
| Previous Close | 7.24 |
| Day's Range | 7.22 - 7.63 |
| 52-Week Range | 6.85 - 24.99 |
| Beta | -0.07 |
About CGEM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CGEM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CGEM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+7.66%
Cullinan Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
7 months ago
+8.44%
Cullinan Therapeutics shares are trading higher after the FDA cleared the company's IND application for CLN-978.
